Reviewed by Michael Gill, B. Sc.
13 Keloid Clinical Trials Near Me
Top Hospitals for Keloid Clinical Trials
Image of Icahn School of Medicine at Mount Sinai in New York.
Icahn School of Medicine at Mount Sinai
New York
2Active Trials
1All Time Trials for Keloid
2021First Keloid Trial
Image of Yale New Haven Hospital in Connecticut.
Yale New Haven Hospital
New Haven
1Active Trials
1All Time Trials for Keloid
2022First Keloid Trial
Top Cities for Keloid Clinical Trials
Image of New York in New York.
New York
3Active Trials
Icahn School of Medicine at Mount SinaiTop Active Site
Image of Bronx in New York.
2Active Trials
Albert Einstein College of MedicineTop Active Site
Keloid Clinical Trials by Phase of Trial
Phase < 1 Keloid Clinical Trials
2Active Keloid Clinical Trials
2Number of Unique Treatments
2Number of Active Locations
Most Recent Keloid Clinical Trials
Clinical Trial
Began Recruiting Date
Top Treatments for Keloid Clinical Trials
Treatment Name
Active Keloid Clinical Trials
All Time Trials for Keloid
First Recorded Keloid Trial
Preoperative silicone ointment
Botulinum toxin type A
Radiation therapy of unresected keloids

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 20th, 2021

Last Reviewed: November 29th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References1 O'Brien L, Jones DJ. Silicone gel sheeting for preventing and treating hypertrophic and keloid scars. Cochrane Database Syst Rev. 2013 Sep 12;(9):CD003826. doi: 10.1002/14651858.CD003826.pub3. Review. Shaarawy E, Hegazy RA, Abdel Hay RM. Intralesional botulinum toxin type A equally effective and better tolerated than intralesional steroid in the treatment of keloids: a randomized controlled trial. J Cosmet Dermatol. 2015 Jun;14(2):161-6. doi: 10.1111/jocd.12134. Epub 2015 Mar 24. Bi M, Sun P, Li D, Dong Z, Chen Z. Intralesional Injection of Botulinum Toxin Type A Compared with Intralesional Injection of Corticosteroid for the Treatment of Hypertrophic Scar and Keloid: A Systematic Review and Meta-Analysis. Med Sci Monit. 2019 Apr 22;25:2950-2958. doi: 10.12659/MSM.916305. Tran B, Wu JJ, Ratner D, Han G. Topical Scar Treatment Products for Wounds: A Systematic Review. Dermatol Surg. 2020 Dec;46(12):1564-1571. doi: 10.1097/DSS.0000000000002712. Balci DD, Inandi T, Dogramaci CA, Celik E. DLQI scores in patients with keloids and hypertrophic scars: a prospective case control study. J Dtsch Dermatol Ges. 2009 Aug;7(8):688-92. doi: 10.1111/j.1610-0387.2009.07034.x. Epub 2009 Feb 18. English, German. Cocco A, Albanese A. Recent developments in clinical trials of botulinum neurotoxins. Toxicon. 2018 Jun 1;147:77-83. doi: 10.1016/j.toxicon.2017.08.014. Epub 2017 Aug 14. Review. Shah GK. Efficacy of diode laser for treating acne keloidalis nuchae. Indian J Dermatol Venereol Leprol. 2005 Jan-Feb;71(1):31-4. Battle EF Jr, Hobbs LM. Laser-assisted hair removal for darker skin types. Dermatol Ther. 2004;17(2):177-83. Review.